Article · 20 May 2025
Review articlePublished 21 Jul 2016
Emerging drugs for atrial fibrillation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atrial fibrillation is associated with excess morbidity and mortality, especially in the elderly. There are two approaches to the management of patients with atrial fibrillation: rate control or maintenance of sinus rhythm with antiarrhythmic medications. Depending on a patient’s risk profile, both strategies may require anticoagulation. Management of atrial fibrillation may be challenging owing to side effects associated with drugs such as warfarin and antiarrhythmic agents. However, there are currently ongoing efforts to develop newer, safer and more tolerable drugs to treat this nuisance arrhythmia. This article deals with the emerging drugs as potential targets for the management of atrial fibrillation.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Practice.
Article · 20 May 2025
Histological effects of doxorubicin and baobab plants on some organs of rat
Article · 28 Mar 2025
Using
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “David Singh”
- BylineArticles whose byline prints “Steven Singh”
